VGR vs. VOR

Last updated Apr 1, 2026

Compare and contrast key facts about Vector Group Ltd. (VGR) and Vor Biopharma Inc. (VOR).

Performance

VGR vs. VOR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vector Group Ltd. (VGR) and Vor Biopharma Inc. (VOR). The values are adjusted to include any dividend payments, if applicable.

VGR vs. VOR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
VGR Vector Group Ltd.	0.00%	0.00%	39.63%	1.92%	11.51%	112.02%
VOR Vor Biopharma Inc.	36.39%	-41.08%	-50.67%	-66.17%	-42.77%	-69.01%

Fundamentals

Total Revenue (TTM) VGR : $1.42B VOR : $0.00
Gross Profit (TTM) VGR : $474.37M VOR : $0.00
EBITDA (TTM) VGR : $364.11M VOR : -$371.64M

Returns By Period

VGR

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

VOR

• 1D: 21.36%
• 1M: 15.54%
• YTD: 36.39%
• 6M: -63.38%
• 1Y: 24.32%
• 3Y*: -45.06%
• 5Y*: -52.97%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

VGR vs. VOR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VOR

VOR Risk / Return Rank: 59
VOR Sharpe Ratio Rank: 46
VOR Sortino Ratio Rank: 76
VOR Omega Ratio Rank: 79
VOR Calmar Ratio Rank: 47
VOR Martin Ratio Rank: 45

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VGR vs. VOR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vector Group Ltd. (VGR) and Vor Biopharma Inc. (VOR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	VGR	VOR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.13	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.45	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.44	—

Correlation

The correlation between VGR and VOR is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

VGR vs. VOR - Dividend Comparison

Neither VGR nor VOR has paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
VGR Vector Group Ltd.	0.00%	0.00%	4.00%	7.09%	6.75%	57.77%	6.87%	11.66%	16.05%	6.98%	6.87%	6.62%
VOR Vor Biopharma Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

Drawdown Indicators

	VGR	VOR	Difference
Max Drawdown Largest peak-to-trough decline	—	-99.72%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-87.15%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-99.61%	—
Current Drawdown Current decline from peak	—	-98.35%	—
Average Drawdown Average peak-to-trough decline	—	-88.36%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	57.88%	—

Volatility

Volatility by Period

	VGR	VOR	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	29.30%	—
Volatility (6M) Calculated over the trailing 6-month period	—	104.24%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	187.43%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	117.27%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	118.05%	—

Financials